Article Cited by others

RESEARCH LETTER

Modulation of inflammatory pain in response to a CCR2/CCR5 antagonist in rodent model

Okamoto Masayuki, Suzuki Takeshi, Watanabe Nobuhide

Year : 2013| Volume: 4| Issue : 3 | Page no: 208-210

   This article has been cited by
 
1 Agarose Spot as a Comparative Method for in situ Analysis of Simultaneous Chemotactic Responses to Multiple Chemokines
Mohaned Ahmed,Haneen A. Basheer,Jose M. Ayuso,Djevdet Ahmet,Marco Mazzini,Roshan Patel,Steven D. Shnyder,Victoria Vinader,Kamyar Afarinkia
Scientific Reports. 2017; 7(1)
[Pubmed]  [Google Scholar] [DOI]
2 Neuropathic pain inhibitor, RAP-103, is a potent inhibitor of microglial CCL1/CCR8
Mami Noda,Daichi Tomonaga,Kota Kitazono,Yusaku Yoshioka,Jiadai Liu,Jean-Philippe Rouseau,Richard Kinkead,Michael R. Ruff,Candace B. Pert
Neurochemistry International. 2017;
[Pubmed]  [Google Scholar] [DOI]
3 Analgesic effects evoked by a CCR2 antagonist or an anti-CCL2 antibody in inflamed mice
María Llorián-Salvador,Marta Pevida,Sara González-Rodríguez,Ana Lastra,María-Teresa Fernández-García,Agustín Hidalgo,Ana Baamonde,Luis Menéndez
Fundamental & Clinical Pharmacology. 2016; 30(3): 235
[Pubmed]  [Google Scholar] [DOI]
4 Chemokine receptors on T cells in multiple sclerosis
Wakiro Sato
Clinical and Experimental Neuroimmunology. 2014; 5(2): 162
[Pubmed]  [Google Scholar] [DOI]
5 Chemokine (C-C motif) Receptor 5 Is an Important Pathological Regulator in the Development and Maintenance of Neuropathic Pain
Katsuyuki Matsushita,Hidetoshi Tozaki-Saitoh,Chinami Kojima,Takahiro Masuda,Makoto Tsuda,Kazuhide Inoue,Sumio Hoka
Anesthesiology. 2014; 120(6): 1491
[Pubmed]  [Google Scholar] [DOI]

 

Read this article